Gabriel S Weatherhead

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriel S Weatherhead. Retrieved from https://idiyas.com/inventor/gabriel-s-weatherhead

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 8.3

ph-index = 8

Forward Citations = 140(Granted Patents)

Location History:

Salem, MA (US) (2011 - 2013)
Tewksbury, MA (US) (2013 - 2016)
Cambridge, MA (US) (2008 - 2021)

Company Filing History:

13 out of 854

Millennium Pharmaceuticals Limited

patents

Years Active: 2008-2021

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11014928 - Compounds and methods for inhibiting mitotic progression (2021-05-25),

2. 10414770 - Compounds and methods for inhibiting mitotic progression (2019-09-17),

3. 9765078 - Compounds and methods for inhibiting mitotic progression (2017-09-19),

4. 9458108 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2016-10-04),

5. 9150525 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2015-10-06),

6. 9102678 - Compounds and methods for inhibiting mitotic progression (2015-08-11),

7. 8901136 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2014-12-02),

8. 8481550 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2013-07-09),

9. 8399659 - Compounds and methods for inhibiting mitotic progression (2013-03-19),

10. 8008307 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2011-08-30),

11. 7935694 - Lactam compounds useful as protein kinase inhibitors (2011-05-03),

12. 7572784 - Compounds and methods for inhibiting mitotic progression (2009-08-11),

13. 7459448 - Lactam compounds useful as protein kinase inhibitors (2008-12-02),

Title: Innovator Spotlight: Gabriel S Weatherhead

Introduction:

Gabriel S Weatherhead, a prolific inventor based in Cambridge, MA, has made significant contributions to the field of cancer treatment through his groundbreaking innovations and patented technologies.

Latest Patents:

Weatherhead's latest patents include "Compounds and methods for inhibiting mitotic progression." This invention focuses on developing compounds that target Aurora kinase to effectively treat cancer. The pharmaceutical compositions and treatment methods outlined in these patents showcase Weatherhead's dedication to advancing cancer therapeutics.

Career Highlights:

With an impressive portfolio of 13 patents, Gabriel S Weatherhead has demonstrated a deep commitment to pushing the boundaries of medical science. His work at Millennium Pharmaceuticals Limited has been instrumental in driving forward novel approaches to cancer treatment, benefiting patients worldwide.

Collaborations:

Weatherhead has collaborated with esteemed professionals in the field, including coworkers Christopher F Claiborne and Lloyd J Payne. These partnerships have enabled him to exchange ideas, pool expertise, and bring impactful innovations to fruition.

Conclusion:

Gabriel S Weatherhead's inventions in cancer treatment underscore his talent as a visionary inventor. His relentless pursuit of novel compounds and treatment methods exemplifies the spirit of innovation that propels the medical community towards better healthcare solutions.

Profile summary based on public USPTO records.